Strumento inattivo

Pubblicazioni ufficiali THERACLION N Euronext Paris

Azioni

Prezzo di chiusura Euronext Paris Altri mercati azionari
- ^EUR	-

25/06	Borsa di Italia: Bang!
24/06	Completati i trattamenti dello studio pivotale Sonovein della FDA: Theraclion raggiunge una pietra miliare chiave nel rispetto dei tempi previsti	CI

Minutes of the general assembly	18/06	CO
Mixed general shareholder meeting	31/05	CO
Mixed general shareholder meeting	13/05	CO
Financial report	25/04	CO
Monthly statement on voting rights	31/03	CO
Annual results	27/03	CO
Annual results	27/03	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	01/02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase/Subscription	30/01	CO
4th quarter turnover	29/01	CO
4th quarter turnover	29/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	31/10/23	CO
Half-year report	30/10/23	CO
1st-half-year results	11/10/23	CO
1st-half-year results	11/10/23	CO
Monthly statement on voting rights	30/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Monthly statement on voting rights	31/07/23	CO
Minutes of the general assembly	29/06/23	CO
Admission of new securities	22/06/23	CO
Admission of new securities	22/06/23	CO
Mixed general shareholder meeting	14/06/23	CO
Monthly statement on voting rights	31/05/23	CO